For Immediate Release

Itamar Medical’s WatchPAT™ Ambulatory Device for Diagnosing Sleep Related Breathing Disorders and Sleep Staging Receives CPT® Code From the AMA

 

July 7, 2009

TEL AVIV, Israel -- The American Medical Association (AMA) has awarded Itamar-Medical’s WatchPAT™ device a Category III CPT (Current Procedural Terminology) code. A level III code will allow the medical community to begin the process of collecting much necessary usage information. This information, in turn, will be critical when the process moves to determining a reimbursement value for which a Category I code is expected in the near future.

In March 2009 WatchPAT was formally recognized by Medicare as being nationally covered for reimbursement across the US. The California Technology Assessment Forum (the technology assessment arm of Blue Shield of California) recently approved WatchPAT as directly affecting patient outcome out of 36 reviewed devices for sleep testing (only one other device was approved).

“We are excited to finally receive this important recognition of WatchPAT from the AMA. We are confident the medical community at large will benefit from the reliability and ease of use WatchPAT offers,” said Dr. Dov Rubin, President and CEO of Itamar Medical.

WatchPAT is the most scientifically and clinically investigated ambulatory device for sleep related breathing disorders and sleep staging. It offers physicians the ability to fully analyze the 6 channels of tamper-proof, sleep-related data and manually edit the suggested automatic analysis in a manner similar to standard PSG (Polysomnograph) recordings. Used by physicians across the US on over 120,000 patients, WatchPAT has made Itamar-Medical the leader in home sleep testing.

 

 

 

Print this release.